Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > Hard to Believe
View:
Post by retiredcf on Apr 29, 2022 7:58am

Hard to Believe

May have to buy some more today. GLTA

Symbol/ Company Price $ Change $ Volume
Data delayed at least 15 minutes, as of 28/04/2022 2:47 PM ET | All market data delayed
AKITA Drilling Ltd
$3.50 CAD -$0.50(12.50%) 105.00
Opsens Inc
$1.96 CAD (7.11%) 192.82K
MCI Onehealth Technologies Inc
$1.15 CAD (6.50%) 10.21K
Comment by Lesalpes29 on Apr 29, 2022 8:18am
Bought a small 500 shares at 1.96 yesterday. Over for me... will wait for more news.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities